CRO market shift drives SynteractHCR growth as it moves to new facility

By Melissa Fassbender contact

- Last updated on GMT

(Image: SynteractHCR)
(Image: SynteractHCR)

Related tags: Contract research organization

SynteractHCR has moved to a new 38,000 square foot facility in Carlsbad, CA as it looks to fill the mid-market CRO void created by recent consolidation, says CEO.

Since it was founded in 1987, the contract research organization (CRO) has been headquartered in Carlsbad, CA – a “thrivingbiotech community,” ​which Steve Powell, SynteractHCR CEO, said has been good to the company.

We have longstanding customer relationships, and so it made sense to maintain the headquarters there, while also continuing to expand our East Coast presence in Morrisville, NC and grow across our European facilities​,” Powell told

Powell joined SynteractHCR in July​ of this year at which time he told us​ his goal was to ensure continued innovation. The company also added three senior executives​ to its management team in April.

The move the new facility also follows the company’s completed by the private equity firm Amulet Capital Partners, LP. Powell said the firm has been dedicated to growing the company’s business by improving service delivery.

We see an immediate opportunity to fill the mid-market CRO ‘void’ given recent consolidation in the industry​,” added Powell. “We remain true to developing customer relationships that are a match culturally while delivering per expectations, so this shift in the CRO market is one we see as a key growth driver​.”

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more